Amarin Corp Plc (AMRN)

[postes]

The low lying fruit for R-IT has been picked...for sales to increase dramaticlly AMRN needs 800 sales reps and DTC and all other promotions at their disposal...R-IT is in its infancy. Many many many more doctors don't know about Vascepa than do...drug companies get much more than 8-9 years to promote their drugs and have deep market penetration in most cases.
AMRN at most will have 8-9 years with a sales force that does not have the normal access that an established pharma has so in fact the 8-9 years a BP would have would actually be much less for AMRN...and for the generics they have 0 access.

For these reasons the business model for generics is not to take control of an immature drug but to let the co like AMRN build the business close to 10 fold..Vascepa will have huge penetration and huge sales built on a foundation not on sand but of 8-9 years of hard work..at that point Vascepa will sell on its own...and then the generics would have won the lottery...

"Lemonade stand economics"